INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
30/01/2026
Voltar para busca
Dado oficial do USPTO
MEDSIR MEDICA SCIENTIA INNOVATION RESEARCH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
31/01/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
42
Data de depósito
03/11/2017
Data de registro
13/11/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/05/2025
Última transação
31/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
ES
Examinador
VAGHANI, MAYUR C
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized word "MED SIR" with "MED" in black and "SIR" in orange, the letter "S" has a double helix design in the background in light orange; below is the wording "MEDICA SCIENTIA" in orange and "INNOVATION RESEARCH" in black. The colors white represents background, outlining, shading, and/or transparent areas and is not part of the mark.
Titulares e representantes
Titulares
MEDICA SCIENTIA INNOVATION RESEARCH, S.L.
M. C. (pessoa física)
Representantes
Jason L DeFrancesco Hill Wallack LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific and technological servicesscientific research in the field of oncology; medical and pharmacological research services; consultancy relating to laboratory testing; consultancy relating to research and development in the field of therapeutics; consultancy relating to pharmacology; consultancy relating to pharmaceutical research and development; development of pharmaceutical preparations and medicines; clinical trials for others for test studiescontrol groupsparticipants with cancer; evaluation of pharmaceutical products; scientific and medical information regarding pharmaceutical products and clinical trials; biological researchclinical and medical research in the field of oncology; scientific research with a medical purpose; medical research; scientific research and development; pharmaceutical drug development services; biomedical research services; pharmaceutical research services; laboratory research services relating to pharmaceutical products; medical research laboratory services; medical laboratory services; provision of information regarding results of clinical trials relating to pharmaceutical products
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
C71T
CANCELLED SECTION 71
30/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
13/11/2023
CHLD
CHANGE OF OWNER RECEIVED FROM IB
30/07/2021
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
10/12/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/11/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/10/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/04/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
16/03/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/02/2019
FIMP
FINAL DISPOSITION PROCESSED
26/02/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/02/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
13/11/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/08/2018
PUBO
PUBLISHED FOR OPPOSITION
28/08/2018
GPNX
NOTIFICATION PROCESSED BY IB
24/08/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/08/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/08/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/08/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/07/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
20/07/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
20/07/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
20/07/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
20/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2018
ALIE
ASSIGNED TO LIE
26/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2018
RFNT
REFUSAL PROCESSED BY IB
07/04/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/03/2018
RFRR
REFUSAL PROCESSED BY MPU
21/03/2018
MAFR
APPLICATION FILING RECEIPT MAILED
16/03/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/03/2018
CNRT
NON-FINAL ACTION WRITTEN
14/03/2018
DOCK
ASSIGNED TO EXAMINER
12/03/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/03/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/03/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MEDSIR MEDICA SCIENTIA INNOVATION RESEARCH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.